Hepatic steatosis and cardiovascular risk in diabetic patient type 2

Endocrine Abstracts ◽

10.1530/endoabs.63.p953 ◽

2019 ◽

Author(s):

Halima Fennoun ◽

Souhaila El Mansouri ◽

Mohamed Tahiri ◽

Siham El Aziz ◽

Farid Haddad ◽

...

Keyword(s):

Cardiovascular Risk ◽

Diabetic Patient ◽

Hepatic Steatosis ◽

Download Full-text

Detection of metabolic hepatic steatosis in type 2 diabetic patient: about 281 cases

Endocrine Abstracts ◽

10.1530/endoabs.63.p949 ◽

2019 ◽

Author(s):

Halima Fennoun ◽

Souhaila El Mansouri ◽

Mohamed Tahiri ◽

Siham El Aziz ◽

Farid Haddad ◽

...

Keyword(s):

Diabetic Patient ◽

Hepatic Steatosis ◽

Type 2 Diabetic

Download Full-text

W09.216 Coronary calcification score and conventional cardiovascular risk factors in asymptomatic type 2 diabetic subjects: The predict study

Atherosclerosis ◽

10.1016/s0021-9150(04)90215-8 ◽

2004 ◽

Vol 5 (1) ◽

pp. 50

Author(s):

R ELKELES

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Coronary Calcification ◽

Calcification Score ◽

Predict Study ◽

Type 2 Diabetic

Download Full-text

Abstract #415 Peripheral Arterial Disease and Its Association with Cardiovascular Risk Factors in Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)47176-9 ◽

2018 ◽

Vol 24 ◽

pp. 103-104

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoor

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Peripheral Arterial Disease ◽

Cardiovascular Risk Factors ◽

Arterial Disease ◽

Peripheral Arterial

Download Full-text

Abstract #414 Ambulatory Blood Pressure Monitoring and Correlation with Cardiovascular Risk Markers in Type 2 Diabetes In Association with The Prevalence of Non-Dippers

Endocrine Practice ◽

10.1016/s1530-891x(20)47175-7 ◽

2018 ◽

Vol 24 ◽

pp. 103

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoor

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Ambulatory Blood Pressure Monitoring ◽

Ambulatory Blood Pressure ◽

Blood Pressure Monitoring ◽

Risk Markers ◽

Pressure Monitoring

Download Full-text

Abstract #412 Impact of High Fibre Diet on Cardiovascular Risk Markers in Comorbidity of Hypertension and Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)47173-3 ◽

2018 ◽

Vol 24 ◽

pp. 102

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoo

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Markers ◽

High Fibre Diet ◽

Download Full-text

Abstract #381 The Relation of Obesity, Insulin Resistance and Cardiovascular Risk in Type 2 Diabetic Patients in Sudan

Endocrine Practice ◽

10.1016/s1530-891x(20)46725-4 ◽

2019 ◽

Vol 25 ◽

pp. 174-175

Author(s):

Sulaf Abdelaziz ◽

Eltohami Dafalla

Keyword(s):

Insulin Resistance ◽

Cardiovascular Risk ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Type 2 Diabetic

Download Full-text

Abstract #259: Cardiovascular Risk Factors Among Type 2 Diabetic Subjects Attending Selected Diabetes Care Facilities in Bangladesh

Endocrine Practice ◽

10.1016/s1530-891x(20)44379-4 ◽

2017 ◽

Vol 23 ◽

pp. 62

Author(s):

Md Fazlarabbi Khan ◽

M. Samad

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Diabetes Care ◽

Care Facilities ◽

Type 2 Diabetic

Download Full-text

Empagliflozin improves glycemic parameters and cardiovascular risk factors in patients with Type 2 Diabetes (T2DM): Pooled data from four pivotal phase III trials

Diabetologie und Stoffwechsel ◽

10.1055/s-0034-1374999 ◽

2014 ◽

Vol 9 (S 01) ◽

Author(s):

T Hach ◽

J Gerich ◽

A Salsali ◽

G Kim ◽

S Hantel ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Phase Iii ◽

Pivotal Phase ◽

Pooled Data ◽

Phase Iii Trials

Download Full-text

Significant impact of the presence of type 2 diabetes on the cardiovascular risk conferred by the plasminogen activator inhibitor-1–675 5G/4G polymorphism

Diabetologie und Stoffwechsel ◽

10.1055/s-2007-984788 ◽

2007 ◽

Vol 2 (04) ◽

Author(s):

A Muendlein ◽

CH Saely ◽

T Marte ◽

L Koch ◽

F Schmid ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor 1 ◽

Activator Inhibitor

Download Full-text

Cardiovascular Risk Prediction in Type 2 Diabetes Patients

Medical Connections ◽

10.33311/medcon.2016.40.4.3 ◽

2016 ◽

Vol 40 (4/2016) ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Prediction ◽

Cardiovascular Risk Prediction ◽

Diabetes Patients

Download Full-text